Skip to content
NewA calmer, faster ZeroHour

Eli Lilly CEO calls Amodei’s disease-cure timeline unlikely

Original title: Eli Lilly CEO pushes back on Dario Amodei's ludicrous medical claims

Hacker News · securityby Noaidi ()6 min read1
AI summary · x-ai/grok-4.7Summaries by Vani AI

Dave Ricks said biology is still largely unmapped and human proof, not model forecasts, is the long pole in drug development.

Anthropic CEO Dario Amodei said cancer, Alzheimer’s, heart disease and mental illness could be relics of the past in less than a decade, in remarks tied to an IPO video. Eli Lilly chairman and CEO Dave Ricks replied that such an outcome would be amazing but is not likely, and that progress from AI in medicine will probably be steady and incremental. Gary Marcus and several researchers argued clinical timelines make that prediction unrealistic.

Unconfirmed: The disease-cure timeline is Amodei’s prediction; researchers and Ricks dispute it, and the clinical-timeline figures come from social-media comments.

Key facts
  • Amodei’s quoted horizon is less than a decade for those diseases.
  • Ricks said randomized human proof remains the constraint.
  • One cited figure: mean time from first-in-human to FDA approval was 14 years for 20 recent drugs.
  • Marcus frames the claims as overpromising comparable to Theranos rhetoric.
Explain this AI news with Vani AIWhat was announced, what is new and why it matters, in a new chat

From the original article

6 min read at garymarcus.substack.com

Moments after I posted my essay on why I couldn’t touch Anthropic’s IPO with a ten-foot pole, Anthropic’s CEO gave me (and everyone else) a reason to run away as fast as possible: a video tied to the IPO launch in which he made a bunch of overpromise about medicine that would have made Elizabeth Holmes blush.

Hacker News · security

By Noaidi · garymarcus.substack.com

Read the full article at Hacker News · security

A short excerpt; the article and its images belong to the publisher. Summary, key facts and assessment above are AI-written from the article and can be wrong.